JP2014108932A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014108932A5 JP2014108932A5 JP2012263367A JP2012263367A JP2014108932A5 JP 2014108932 A5 JP2014108932 A5 JP 2014108932A5 JP 2012263367 A JP2012263367 A JP 2012263367A JP 2012263367 A JP2012263367 A JP 2012263367A JP 2014108932 A5 JP2014108932 A5 JP 2014108932A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- persicalin
- hyperin
- diabetic
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 12
- 208000002249 Diabetes Complications Diseases 0.000 claims 7
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 claims 6
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-β-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 claims 6
- 206010012655 Diabetic complications Diseases 0.000 claims 4
- 239000004480 active ingredient Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 230000002401 inhibitory effect Effects 0.000 claims 2
- -1 oral jelly Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 108010005094 Advanced Glycation End Products Proteins 0.000 claims 1
- 208000004205 Diabetic Angiopathy Diseases 0.000 claims 1
- 208000007342 Diabetic Nephropathy Diseases 0.000 claims 1
- 208000001636 Diabetic Neuropathy Diseases 0.000 claims 1
- 206010063547 Diabetic macroangiopathy Diseases 0.000 claims 1
- 206010061835 Diabetic nephropathy Diseases 0.000 claims 1
- 206010012680 Diabetic neuropathy Diseases 0.000 claims 1
- 206010012689 Diabetic retinopathy Diseases 0.000 claims 1
- 229940041672 Oral Gel Drugs 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 239000007795 chemical reaction product Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 235000013376 functional food Nutrition 0.000 claims 1
- 230000036252 glycation Effects 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 235000012054 meals Nutrition 0.000 claims 1
- 239000002324 mouth wash Substances 0.000 claims 1
- 239000000668 oral spray Substances 0.000 claims 1
- 239000007935 oral tablet Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 239000006188 syrup Substances 0.000 claims 1
- 235000020357 syrup Nutrition 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012263367A JP6101060B2 (ja) | 2012-11-30 | 2012-11-30 | 終末糖化産物生成抑制剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012263367A JP6101060B2 (ja) | 2012-11-30 | 2012-11-30 | 終末糖化産物生成抑制剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014108932A JP2014108932A (ja) | 2014-06-12 |
| JP2014108932A5 true JP2014108932A5 (es) | 2016-06-23 |
| JP6101060B2 JP6101060B2 (ja) | 2017-03-22 |
Family
ID=51029773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012263367A Expired - Fee Related JP6101060B2 (ja) | 2012-11-30 | 2012-11-30 | 終末糖化産物生成抑制剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6101060B2 (es) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09266767A (ja) * | 1996-03-29 | 1997-10-14 | Meiji Seika Kaisha Ltd | サンザシ抽出物入り持久力向上飲食品 |
| DE102007029042A1 (de) * | 2007-06-21 | 2008-12-24 | Analyticon Discovery Gmbh | Pharmazeutische Zusammensetzung mit einem Trihydroxychromenone-Derivate |
| MX2013001906A (es) * | 2010-09-17 | 2013-07-05 | Stokely Van Camp Inc | Metodos para reducir la concentracion de lactato en la sangre. |
-
2012
- 2012-11-30 JP JP2012263367A patent/JP6101060B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2014207770A8 (en) | A medicinal composition of amaranth extract origin having enriched nitrate content and a method of preparing the same | |
| HRP20240115T1 (hr) | Povećavanje bioraspoloživosti lijeka u terapiji naltreksonom | |
| WO2016060517A3 (ko) | 신규한 3-(4- (벤질옥시)페닐)핵스- 4-이노익 산 유도체 및 다른 유효 성분을 포함하는 대사성 질환의 예방 또는 치료용 복합제제 | |
| WO2011090409A3 (ru) | Кормовой продукт для продуктивных сельскохозяйственных животных и птиц | |
| JP6445686B2 (ja) | ジペノサイド７５の抗糖尿病効果 | |
| JP2014129323A5 (es) | ||
| JP2014129321A5 (es) | ||
| JP2014129322A5 (es) | ||
| WO2011052935A3 (ko) | 토복령, 여주 및 동충하초 추출물을 유효성분으로 포함하는 혈당 강하용 조성물 | |
| JP2014108932A5 (es) | ||
| JP2009507510A5 (es) | ||
| JP2008266203A (ja) | 活性酸素種消去酵素群の活性を向上させる方法 | |
| JP6464389B2 (ja) | 高血圧症の予防治療剤、及びこれを配合した機能性食品、並びにヤナギタデの芽の乾燥物 | |
| CN103719840A (zh) | 一种竹叶黄酮咀嚼片的加工工艺 | |
| JP2010030950A (ja) | メタボリックシンドローム予防・治療剤ならびに機能性食品 | |
| JP5848428B2 (ja) | 経口用医薬組成物および機能性食品 | |
| FI3193859T3 (fi) | Valmisteet alkoholipunoituksen ja alkoholin indusoimien yliherkkyysreaktioiden hoitamiseksi ja ehkäisemiseksi | |
| WO2012141615A3 (ru) | Лекарственное средство | |
| WO2010142400A3 (de) | Zusammensetzungen auf basis von chitosan-oligosacchariden | |
| JP2014198687A (ja) | 抗炎症作用を増強させたプロポリス・ケルセチン含有組成物 | |
| JP2011111421A (ja) | むくみの予防又は改善作用を有する組成物 | |
| JP2005200390A (ja) | 持久力増強剤および抗疲労剤 | |
| Berdnik et al. | Analysis of the market of oral anti-diabetic medicinal products in Ukraine | |
| Akpinar | Fluoxetine overdose | |
| JP2014129324A5 (es) |